Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

A rare case of hair loss was linked to breast cancer spreading to the scalp, but treatment was effective.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

Certain genes in fat tissue affect weight loss in women with PCOS.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Increased calcium in hair may signal early bone health issues in menopausal women.

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

TrichoScan accurately measures hair growth and loss, showing increased hair counts and thickness with treatment.

Combining hair x-ray diffraction with mammography improves breast cancer detection.

TrichoScan effectively diagnoses different types of hair loss and is linked to low iron stores in patients.

TrichoScan accurately measures hair growth and showed improved hair counts and thickness after finasteride treatment.

A new method accurately measures DHEAS in blood, improving on current tests.

TrichoScan® is a reliable tool for measuring hair growth, providing quicker and more consistent results than manual methods.

DALL-E 2 is only accurate for acne in pediatric dermatology and needs better data for other conditions.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

X-ray diffraction of hair might help detect breast cancer non-invasively.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

TrichoScan offers a painless way to analyze and manage hair loss.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

The modified wash test is better than TrichoScan® for diagnosing hair loss.

TrichoScan needs optimization as it underestimated hair density by 38.9% compared to manual counting.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The TrichoScan method effectively measures hair growth and helps choose patients for hair restoration surgery.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.